Efficacy and safety of mirikizumab as induction and maintenance treatment in adults 60 years or older with moderately to severely active ulcerative colitis

被引：0
|
作者：
Sturm, A. [1 ]
Sebastian, S. [2 ]
Faye, A. S. [3 ]
Armuzzi, A. [4 ]
Buisson, A. [5 ]
Halfvarson, J. [6 ]
Zeissig, S. [7 ,8 ]
Kochar, B. [9 ]
Maier, S. [10 ]
Redondo, I [10 ]
Moses, R. E. [10 ]
Keohane, A. [11 ]
Watanabe, K. [12 ]
机构：
[1] DRK Kliniken Berlin Westend, Dept Gastroenterol, Berlin, Germany
[2] Hull Univ Teaching Hosp, IBD Unit, Kingston Upon Hull, England
[3] NYU Langone Hlth, Inflammatory Bowel Dis Ctr, New York, NY USA
[4] IRCCS Humanitas Res Hosp, IBD Ctr, Milan, Italy
[5] Univ Clermont Auvergne, CHU Clermont Ferrand, Serv Hepatogastroenterol, Inserm,3iHP, Clermont Ferrand, France
[6] Orebro Univ, Dept Gastroenterol, Orebro, Sweden
[7] Univ Med Greifswald, Dept Internal Med A, Greifswald, Germany
[8] Tech Univ TU Dresden, Med Fac, Dresden, Germany
[9] Massachusetts Gen Hosp, Gastroenterol Unit, Boston, MA USA
[10] Eli Lilly & Co, Lilly Immunol, Indianapolis, IN USA
[11] HaaPACS GmbH, Stat Europe, Schriesheim, Germany
[12] Univ Toyama, Dept Internal Med Inflammatory Bowel Dis, Toyama, Japan
来源：
JOURNAL OF CROHNS & COLITIS | 2025年 / 19卷
关键词：
D O I：
10.1093/ecco-jcc/jjae190.1263
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
P1089
引用
收藏
页码：i2005 / i2006
页数：2
相关论文
共 50 条
  • [31] EFFICACY AND SAFETY OF ADVANCED INDUCTION AND MAINTENANCE THERAPIES IN PATIENTS WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS: AN INDIRECT TREATMENT COMPARISON USING BAYESIAN NETWORK META-ANALYSIS
    Panaccione, Remo
    Collins, Eric B.
    Melmed, Gil
    Vermeire, Severine
    Danese, Silvio
    Higgins, Peter D.
    Zhou, Wert
    Ilo, Dapo
    Sharma, Dolly
    Gonzalez, Yuri Sanchez
    Wang, Si-Tien
    GASTROENTEROLOGY, 2022, 162 (07) : S965 - S965
  • [32] Efficacy and safety of advanced induction and maintenance therapies in patients with moderately to severely active Ulcerative Colitis: An indirect treatment comparison using Bayesian network meta-analysis
    Panaccione, R.
    Collins, E. B.
    Melmed, G. Y.
    Vermeire, S.
    Danese, S.
    Higgins, P. D. R.
    Zhou, W.
    Ilo, D.
    Sharma, D.
    Gonzalez, Y. Sanchez
    Wang, S. T.
    JOURNAL OF CROHNS & COLITIS, 2022, 16 : I037 - I041
  • [33] Sustained Symptom Control With Mirikizumab in Patients With Moderately-to-Severely Active Ulcerative Colitis in the LUCENT-2 Maintenance Trial
    Dignass, Axel
    Danese, Silvio
    Matsuoka, Katsuyoshi
    Ferrante, Marc
    Long, Millie
    Redondo, Isabel
    Gibble, Theresa Hunter
    Moses, Richard
    Li, Xingyuan
    Morris, Nathan
    Milch, Catherine
    Abreu, Maria T.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2022, 117 (10): : S558 - S558
  • [34] The Impact of Mirikizumab Induction, Maintenance, and Long-Term Treatment on Disease Clearance in Patients With Moderately to Severely Active Ulcerative Colitis: Post-Hoc Analysis of LUCENT Trials
    Colombel, Jean-Frederic
    Kobayashi, Taku
    Wu, Jianmin
    Zhu, Baojin
    Jairath, Vipul
    Redondo, Isabel
    Moses, Richard
    Siegel, Corey A.
    Siegmund, Britta
    Magro, Fernando
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2024, 119 (10S): : S1079 - S1080
  • [35] Efficacy and safety of advanced therapies for moderately to severely active ulcerative colitis in induction and maintenance: systematic literature review and Bayesian network meta-analysis
    Jairath, Vipul
    Raine, Tim
    Leahy, Thomas P.
    Potluri, Ravi
    Wosik, Karolina
    Gruben, David
    Cappelleri, Joseph C.
    Hur, Peter
    Bartolome, Lauren
    JOURNAL OF COMPARATIVE EFFECTIVENESS RESEARCH, 2025,
  • [36] Efficacy and safety of upadacitinib for 16-week extended induction and 52-week maintenance therapy in patients with moderately to severely active ulcerative colitis
    Panaccione, Remo
    Danese, Silvio
    Zhou, Wen
    Klaff, Justin
    Ilo, Dapo
    Yao, Xuan
    Levy, Gweneth
    Higgins, Peter D. R.
    Loftus Jr, Edward V.
    Chen, Su
    Gonzalez, Yuri Sanchez
    Leonard, Carolyn
    Hebuterne, Xavier
    Lindsay, James O.
    Cao, Qian
    Nakase, Hiroshi
    Colombel, Jean-Frederic
    Vermeire, Severine
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2024, 59 (03) : 393 - 408
  • [37] Long-Term Efficacy of Adalimumab for Treatment of Moderately to Severely Active Ulcerative Colitis
    Colombel, Jean-Frederic
    Sandborn, William
    Wolf, Doug
    Panaccione, Remo
    Lazar, Andreas
    Kron, Martina
    Robinson, Anne
    Thakkar, Roopal
    INFLAMMATORY BOWEL DISEASES, 2012, 18 : S20 - S21
  • [38] Long-Term Efficacy of Adalimumab for Treatment of Moderately to Severely Active Ulcerative Colitis
    Colombel, Jean-Frederic
    Sandborn, William
    Wolf, Douglas
    Panaccione, Remo
    Lazar, Andreas
    Kron, Martina
    Robinson, Anne
    Thakkar, Roopal
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2012, 107 : S652 - S652
  • [39] Adalimumab for Induction of Histological Remission in Moderately to Severely Active Ulcerative Colitis
    Ignacio Fernandez-Blanco, J.
    Fernandez-Diaz, Guillermo
    Cara, Carlos
    Vera, Maria I.
    Olivares, David
    Taxonera, Carlos
    DIGESTIVE DISEASES AND SCIENCES, 2018, 63 (03) : 731 - 737
  • [40] Adalimumab for Induction of Clinical Remission in Moderately to Severely Active Ulcerative Colitis
    Reinisch, Walter
    Sandborn, William J.
    Hommes, Daniel W.
    D'Haens, Geert R.
    Hanauer, Stephen B.
    Schreiber, Stefan
    Panaccione, Remo
    Fedorak, Richard N.
    Tighe, Mary Beth
    Huang, Bidan
    Lazar, Andreas
    GASTROENTEROLOGY, 2010, 138 (05) : S114 - S115
12345